Jim Simons’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,113,400
| Closed | -$10.2M | – | 3848 |
|
|
2025
Q2 | $10.2M | Buy |
1,113,400
+343,700
| +45% | +$2.53M | 0.01% | 1050 |
|
|
2025
Q1 | $6.12M | Buy |
769,700
+318,905
| +71% | +$2.33M | 0.01% | 1305 |
|
|
2024
Q4 | $2.45M | Sell |
450,795
-62,505
| -12% | -$382K | ﹤0.01% | 1924 |
|
|
2024
Q3 | $3.71M | Sell |
513,300
-40,096
| -7% | -$367K | 0.01% | 1640 |
|
|
2024
Q2 | $6.01M | Buy |
553,396
+518,296
| +1,477% | +$6.64M | 0.01% | 1193 |
|
|
2024
Q1 | $658K | Buy |
+35,100
| New | +$810K | ﹤0.01% | 2743 |
|
|
2023
Q4 | – | Sell |
-85,600
| Closed | -$1.76M | – | 4078 |
|
|
2023
Q3 | $1.76M | Buy |
+85,600
| New | +$2.47M | ﹤0.01% | 1938 |
|
|
2022
Q4 | – | Sell |
-12,700
| Closed | -$497K | – | 4361 |
|
|
2022
Q3 | $497K | Sell |
12,700
-30,700
| -71% | -$1.19M | ﹤0.01% | 2935 |
|
|
2022
Q2 | $1.4M | Buy |
+43,400
| New | +$1.45M | ﹤0.01% | 2472 |
|
|
2020
Q3 | – | Sell |
-285,800
| Closed | -$11.9M | – | 3640 |
|
|
2020
Q2 | $11.9M | Sell |
285,800
-461,332
| -62% | -$16.7M | 0.01% | 1124 |
|
|
2020
Q1 | $21.5M | Buy |
747,132
+636,541
| +576% | +$36.9M | 0.02% | 735 |
|
|
2019
Q4 | $7.98M | Buy |
+110,591
| New | +$13.6M | 0.01% | 1587 |
|
|
2018
Q4 | – | Sell |
-2,800
| Closed | -$396K | – | 3576 |
|
|
2018
Q3 | $396K | Sell |
2,800
-163,900
| -98% | -$25.3M | ﹤0.01% | 2927 |
|
|
2018
Q2 | $26.1M | Sell |
166,700
-125,300
| -43% | -$19.7M | 0.03% | 766 |
|
|
2018
Q1 | $47M | Buy |
292,000
+269,069
| +1,173% | +$45.7M | 0.05% | 462 |
|
|
2017
Q4 | $3.78M | Buy |
+22,931
| New | +$2.22M | ﹤0.01% | 1980 |
|
|
2015
Q2 | – | Sell |
-11,100
| Closed | -$558K | – | 3349 |
|
|
2015
Q1 | $558K | Buy |
+11,100
| New | +$477K | ﹤0.01% | 2557 |
|
Other funds holding SAGE
IA
HNB
Jim Simons's SAGE Position: Q3 2025 in Review
Jim Simons sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 1,113,400 shares — an estimated $10.2M sold.
Jim Simons first reported a position in SAGE in Q1 2015 and held it in 17 quarters. The position peaked at $47M in Q1 2018. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Jim Simons reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Jim Simons sold 1,113,400 Sage Therapeutics shares in Q3 2025, an estimated $10.2M.
- Jim Simons first reported a position in Sage Therapeutics in Q1 2015 and held it in 17 quarters.
- Jim Simons's Sage Therapeutics position peaked at $47M in Q1 2018.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.